Stockreport

CytoDyn Announces FDA Has Lifted Clinical Hold [Yahoo! Finance]

CYTODYN INC  (CYDY) 
NASDAQ:AMEX Investor Relations: ir.cytodyn.com
PDF the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the FDA ha [Read more]